United Kingdom · Question · Written question
UIN 106960
Sodium Valproate: Health Services
Original
Introduced
20 January 2026
Last action
29 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
29 January 2026
Summary
To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 January 2026
Written question
To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate.
Source: Commons
29 January 2026
Answer
There are established systems within the National Health Service to ensure that cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate. In practice, this involves establishing arrangements for assessin...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-01-20/106960
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1873487
- uk · wq-1873487 · source updated 29 January 2026